Beam Therapeutics (BEAM)'s 30-day implied volatility (IV30) was 64.1% at the close on October 23, 2026, up from 61.4% the day before, against a 52-week range of 41.8% to 104.1%. Its 20-day historical volatility was 54.9%.
Data as of October 23, 2026.